Purification and characterization of the biliary plasminogen activator bilokinase.

نویسندگان

  • S Oshiba
  • T Ariga
چکیده

The aim of the present study is to elucidate the enzymological and chemical properties of the plasminogen activator in bile, bilokinase. A bilokinase preparation was obtained from 94.2 liters of bovine gall bladder bile through seven purification steps, two of which employed a precipitation method in which ammonium sulfate and acetone were used sequentially. Twenty mg of bilokinase preparation with a specific activity of 5,900 IU/mg were obtained, for a 9% yield with 6,556-fold purification. This preparation revealed a single band upon disc electrophoresis. The bilokinase was a 3.32 S protein and its molecular weight was found to be 57,000. Isoelectric focusing showed that the bilokinase was separable into 5 fractions having different isoelectric points ranging from pH 7.4 to 9.0 The properties of the individual fractions have not yet been determined. The enzymatic activity of bilokinase was recognized to be heat-labile and to be stable at pH 4.0. The activation of plasminogen by bilokinase took place most effectively at pH 7.8 in a manner similar to that of urokinase. In its hydrolysis of both N alpha-acetylglycyl-L-lysine-methyl ester-acetate and H-D-Glu-Gly-Arg-pNA (S-2227), bilokinase showed similar Km values to those of urokinase; however, they were quite distinct from those of plasmin. It was concluded therefore that bilokinase is a plasminogen activator with enzymatic properties which are quite similar to those of the urinary plasminogen activator urokinase. The origin of bilokinase and its relation to liver function are now under investigation.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Optimizing refolding condition for recombinant tissue plasminogen activator

Low molecular size additives such as L-arginine and the redox compounds have been used both in the culturemedium and in vitro refolding to increase recombinant proteins production. Additives increase proteinrefolding and yield of active proteins by suppressing aggregate formation or enhancing refolding process.In this work, a comparative study was performed on refolding of rec...

متن کامل

Blood Coagulation Induced by Iranian Saw-Scaled Viper (Echis Carinatus) Venom: Identification, Purification and Characterization of a Prothrombin Activator

  Objective(s): Echis carinatus is one of the venomous snakes in Iran. The venom of Iranian Echis carinatus is a rich source of protein with various factors affecting the plasma protein and blood coagulation factor. Some of these proteins exhibit types of enzymatic activities. However, other items are proteins with no enzymatic activity.   Materials and Methods: In order to study the mechanism ...

متن کامل

Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.

A urokinase-type plasminogen activator was purified from conditioned media of several human cell cultures, but preferably from the human lung adenocarcinoma line CALU-3 (ATCC, HTB-55), using a combination of chromatography on zinc chelate-Sepharose, SP-Sephadex C-50, and Sephadex G-100. Final yields of 65-100 micrograms/liter of starting material were obtained with a 290-fold purification facto...

متن کامل

Serum Level of Plasminogen Activator Inhibitor Type-1 in Addicted Patients ‎with Coronary Artery Disease

Background: Plasminogen activator inhibitor-1 (PAI-1) is a glycoprotein with inhibitory effects on the formation of plasmin from plasminogen by plasminogen activator. Thus, it prevents clot lysis in vessel walls. Several evidences prove the relationship between coronary artery disease and response to fibrinolytic therapy in patients with myocardial infarction with PAI-1 level. Opium addiction i...

متن کامل

A clinical study investigating the three months prognosis of patients with ischemic stroke treated with recombinant tissue plasminogen activator (rt-PA) and its effective factors

Objective: Currently, treating ischemic stroke by intravenous thrombolytic therapy has acceptable results in patients with stroke. This study aimed to evaluate the three months prognosis of patients treated with recombinant tissue plasminogen activator (rt-PA).Methods: This cross-sectional prospective study was conducted on 30 patients with cerebral ischemic stroke with the National Insti...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Journal of biological chemistry

دوره 258 1  شماره 

صفحات  -

تاریخ انتشار 1983